Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

15.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.7K
Ligand Binding Sites02:40

Ligand Binding Sites

9.1K
9.1K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

15.6K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.6K
Drug Discovery: Overview01:26

Drug Discovery: Overview

13.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computational Resources for Molecular Biology 2026.

Journal of molecular biology·2026
Same author

3DSeqCheck: A Web-based Tool for Verifying Sequence Consistency Between a 3D Structure File and the Corresponding UniProt Entry.

Journal of molecular biology·2026
Same author

The aging of the AlphaFold database.

Nature structural & molecular biology·2025
Same author

Boolean matrix logic programming for active learning of gene functions in genome-scale metabolic network models.

Machine learning·2025
Same author

Computational Resources for Molecular Biology 2025.

Journal of molecular biology·2025
Same author

Phyre2.2: A Community Resource for Template-based Protein Structure Prediction.

Journal of molecular biology·2025

Related Experiment Video

Updated: Mar 30, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.7K

Incorporating Virtual Reactions into a Logic-based Ligand-based Virtual Screening Method to Discover New Leads.

Christopher R Reynolds1, Stephen H Muggleton2, Michael J E Sternberg1

  • 1Department of Bioinformatics, Imperial College London, South Kensington Campus London SW7 2AZ, UK.

Molecular Informatics
|November 20, 2015
PubMed
Summary

This study introduces virtual reactions and a de novo design algorithm to explore vast chemical space for drug discovery. This method generates focused libraries of potential drug derivatives, significantly increasing the chances of finding molecules similar to known active compounds.

Keywords:
LigandMachine learningReactionsSynthesisVirtual screening

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.6K
A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
08:43

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

11.0K

Related Experiment Videos

Last Updated: Mar 30, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.7K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.6K
A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
08:43

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

11.0K

Area of Science:

  • Computational Chemistry
  • Drug Discovery
  • Medicinal Chemistry

Background:

  • Ligand-based virtual screening is crucial in drug development but limited by existing compound databases.
  • Exploring novel chemical space is essential for identifying new drug candidates.
  • Current methods struggle to represent the full potential of chemical diversity.

Purpose of the Study:

  • To develop a method for exploring synthetic chemical space beyond existing databases.
  • To generate focused libraries of predicted drug derivatives using virtual reactions.
  • To enhance the efficiency of drug discovery by identifying novel, potentially active molecules.

Main Methods:

  • Utilized the Investigational Novel Drug Discovery by Example (INDDEx) tool as a foundation for virtual reactions.
  • Developed and integrated the Partial Logical-Rule Reactant Selection (PLoRRS) de novo design algorithm.
  • Applied virtual reactions to promising compounds to generate focused libraries of derivatives.

Main Results:

  • Virtual reactions expand accessible chemical space to an estimated 1.21×1012 potential molecules.
  • The PLoRRS method significantly increases the likelihood of retrieving molecules similar to known actives (p-value=0.016).
  • Case studies confirmed the generation of molecules highly similar to known active drugs.

Conclusions:

  • Virtual reactions combined with PLoRRS offer a powerful approach to explore and expand chemical space for drug discovery.
  • This methodology effectively generates focused libraries of novel compounds with high similarity to known drugs.
  • The system enhances the drug development pipeline by enabling the discovery of new potential therapeutics.